0 NASDAQ Companies - February 25, 2019Sorrento Therapeutics to Present Corporate Update at Two Investor ConferencesRead More
0 NASDAQ Companies - February 25, 2019Summit’s SMT-571 Potent Against Over 200 Clinical Isolates of Neisseria Gonorrhoeae, Including Numerous Multi- and Extensively-Drug Resistant Strains, in Published Preclinical DataRead More
0 NASDAQ Companies - February 25, 2019Agios Reports Updated Data from Phase 1 Study of Ivosidenib in Combination with Azacitidine Demonstrating Deep and Durable Responses in Newly Diagnosed IDH1 Mutant Acute Myeloid Leukemia (AML) PatientsRead More
0 NASDAQ Companies - February 25, 2019Codexis Names Laurie Heilmann Senior Vice President of Business Development and MarketingRead More
0 NASDAQ Companies - February 25, 2019LogicBio Therapeutics to Present at Upcoming March ConferencesRead More
0 NASDAQ Companies - February 25, 2019Karyopharm Strengthens Management Team with Appointment of Michael P. Mason as Chief Financial OfficerRead More
0 NASDAQ Companies - February 25, 2019Athenex to Host Conference Call with Key Opinion Leader Following Oral Presentation of Phase III Results of KX2-391 Ointment in the Treatment of Actinic Keratosis at the American Academy of Dermatology Annual MeetingRead More
0 NASDAQ Companies - February 25, 2019LGI Homes Announces the Grand Opening of its First Community in the Mid-AtlanticRead More
0 TSX News - February 25, 2019Gran Colombia Gold Identifies New Zones in its Final 2018 Drilling Results for its Segovia Operations; Gold Production in January 2019 Remains SteadyRead More
0 TSX News - February 25, 2019First Majestic Announces Financial Results for Q4 and Year End 2018Read More
